Cargando…
The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity
We study the effect of delaying treatment in the presence of (unobserved) heterogeneity. In a homogeneous population and assuming a proportional treatment effect, a treatment delay period will result in notably lower cumulative recovery percentages. We show in theoretical scenarios using frailty mod...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383985/ https://www.ncbi.nlm.nih.gov/pubmed/31957043 http://dx.doi.org/10.1002/bimj.201900131 |
_version_ | 1783563530053615616 |
---|---|
author | van Geloven, Nan Balan, Theodor A. Putter, Hein le Cessie, Saskia |
author_facet | van Geloven, Nan Balan, Theodor A. Putter, Hein le Cessie, Saskia |
author_sort | van Geloven, Nan |
collection | PubMed |
description | We study the effect of delaying treatment in the presence of (unobserved) heterogeneity. In a homogeneous population and assuming a proportional treatment effect, a treatment delay period will result in notably lower cumulative recovery percentages. We show in theoretical scenarios using frailty models that if the population is heterogeneous, the effect of a delay period is much smaller. This can be explained by the selection process that is induced by the frailty. Patient groups that start treatment later have already undergone more selection. The marginal hazard ratio for the treatment will act differently in such a more homogeneous patient group. We further discuss modeling approaches for estimating the effect of treatment delay in the presence of heterogeneity, and compare their performance in a simulation study. The conventional Cox model that fails to account for heterogeneity overestimates the effect of treatment delay. Including interaction terms between treatment and starting time of treatment or between treatment and follow up time gave no improvement. Estimating a frailty term can improve the estimation, but is sensitive to misspecification of the frailty distribution. Therefore, multiple frailty distributions should be used and the results should be compared using the Akaike Information Criterion. Non‐parametric estimation of the cumulative recovery percentages can be considered if the dataset contains sufficient long term follow up for each of the delay strategies. The methods are demonstrated on a motivating application evaluating the effect of delaying the start of treatment with assisted reproductive techniques on time‐to‐pregnancy in couples with unexplained subfertility. |
format | Online Article Text |
id | pubmed-7383985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73839852020-07-28 The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity van Geloven, Nan Balan, Theodor A. Putter, Hein le Cessie, Saskia Biom J Duration and Survival We study the effect of delaying treatment in the presence of (unobserved) heterogeneity. In a homogeneous population and assuming a proportional treatment effect, a treatment delay period will result in notably lower cumulative recovery percentages. We show in theoretical scenarios using frailty models that if the population is heterogeneous, the effect of a delay period is much smaller. This can be explained by the selection process that is induced by the frailty. Patient groups that start treatment later have already undergone more selection. The marginal hazard ratio for the treatment will act differently in such a more homogeneous patient group. We further discuss modeling approaches for estimating the effect of treatment delay in the presence of heterogeneity, and compare their performance in a simulation study. The conventional Cox model that fails to account for heterogeneity overestimates the effect of treatment delay. Including interaction terms between treatment and starting time of treatment or between treatment and follow up time gave no improvement. Estimating a frailty term can improve the estimation, but is sensitive to misspecification of the frailty distribution. Therefore, multiple frailty distributions should be used and the results should be compared using the Akaike Information Criterion. Non‐parametric estimation of the cumulative recovery percentages can be considered if the dataset contains sufficient long term follow up for each of the delay strategies. The methods are demonstrated on a motivating application evaluating the effect of delaying the start of treatment with assisted reproductive techniques on time‐to‐pregnancy in couples with unexplained subfertility. John Wiley and Sons Inc. 2020-01-20 2020-07 /pmc/articles/PMC7383985/ /pubmed/31957043 http://dx.doi.org/10.1002/bimj.201900131 Text en © 2020 The Authors. Biometrical Journal published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Duration and Survival van Geloven, Nan Balan, Theodor A. Putter, Hein le Cessie, Saskia The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity |
title | The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity |
title_full | The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity |
title_fullStr | The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity |
title_full_unstemmed | The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity |
title_short | The effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity |
title_sort | effect of treatment delay on time‐to‐recovery in the presence of unobserved heterogeneity |
topic | Duration and Survival |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383985/ https://www.ncbi.nlm.nih.gov/pubmed/31957043 http://dx.doi.org/10.1002/bimj.201900131 |
work_keys_str_mv | AT vangelovennan theeffectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity AT balantheodora theeffectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity AT putterhein theeffectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity AT lecessiesaskia theeffectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity AT vangelovennan effectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity AT balantheodora effectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity AT putterhein effectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity AT lecessiesaskia effectoftreatmentdelayontimetorecoveryinthepresenceofunobservedheterogeneity |